Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Groklaw
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: GroklawNovell Objects to SCO's Request for More Time; Suggests There May Be No SNCP Deal
By Pamela Jones et al.
If one asks a series of illuminating questions -- why SCO cannot propose a plan without a final judgment given what it now knows from the District Court Litigation and its apparent contention that it does not need to have a result in the Arbitration, how convincing its claim is that it cannot proceed now because others want to know when the appeal will begin, why SCO in all these months since beginning to restructure its deal with SNCP has not been able to do that despite allegedly working at it diligently and why SCO has continued to avoid restarting the Arbitration -- one sees in the obvious lack of good answers to any of these questions accumulating evidence that SCO simply is stalling. Perhaps SCO really has no prospective deal with SNCP or anyone else; perhaps SCO hopes to pressure Novell into either an appeal of only a partial result in the District Court Litigation or into settling the litigation altogether to get it over with. Either way, the Court has additional reason to deny the Third Extension Motion. Stalling is not "cause" to extend the deadlines.
If anyone has time to OCR this for me, I'd appreciate it greatly. Remember, the hearing on SCO's motion is set for September 16. That hearing should be smoking.
Full post as published by Groklaw on September 09, 2008 (boomark / email).
Hurricane Claims
State Farm Fire and Casualty Co. reaches settlement deal with Mississippi Attorney General Jim Hood.
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

Novell Gets $2.5 Million From SCO
With Friends Like These, Who Needs Enemies
Friday Poem: "The Objects in My Room"








